National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.
A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.
A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease.